research bioprinter News
-
3D Bioprinting Solutions and URSC Cooperation Agreement - The Development of a Bioprinter for Space Applications
3D Bioprinting Solutions, a resident company of Skolkovo Innovation Center has entered into a cooperation agreement with URSC (Unified Rocket and Space Corporation, a member of ROSCOSMOS State Corporation), aiming to create a unique bioprinter capable of magnetic biofabrication of tissue and organ constructs in zero-gravity at the International Space Station (ISS). It was signed by the URSC ...
-
VIVAX BIO on a mission for COVID-19 drug discovery
Following its aspiring mission “Creating future opportunities” the biotechnological research laboratory “3D Bioprinting Solutions” and VIVAX BIO take an active part in pharmacological studies of various antiviral drugs. During the most difficult challenge in recent healthcare history cell biologists from the laboratory's research team began working with leading virologists ...
-
BICO acquires Allegro 3D, adding new light-based 3D bioprinting technology – complementing the existing offering of application tailored products
Adding Allegro 3D to the portfolio enables BICO Bioprinting to strengthen its position as the global leader in providing 3D bioprinters. BICO has a robust portfolio of bioprinters, utilizing extrusion based, 2PP and DLP technologies. BICO has acquired all the shares in San Diego-based Allegro 3D Inc. (“Allegro 3D”) for an up-front enterprise value of USD 6 million. Additionally, ...
-
BICO Companies win Red Dot Design Award for Outstanding Product Design
Today, Discover Echo and CYTENA BPS, two companies’ part of the BICO Biosciences business areas were recipients of the illustrious Red Dot Design awards. CYTENA BPS’ S.NEST™ was further recognized as part of the “Best of the Best”, the highest accolade available. “This marks BICO’s third year in a row being recognized by the Red Dot committee, a ...
-
The BICO Group has been awarded 7 iF design awards for excellence in product design
Handed to products that excel in their design and vision, the iF awards are voted on by a jury of 132 leading designers from across the globe with the goal to identify products which demonstrate the adoption of modern design trends and outstanding craftsmanship. For the third year in a row, BICO has taken home the award and extends its haul to 11 iF design awards in total, officially ranking ...
-
Carcinotech and CELLINK Enter a Partnership to Develop and Commercialize Protocols for Cancer Models to Provide Improved Speed and Accuracy in the Drug Development Processes
Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of 3D bioprinted tumor models based on cancer cell lines that improve accuracy and rapidly speed up drug development processes, driving down development costs and enabling an improved output. The protocols will be available for use on the BIO CELLX system ...
By CELLINK
-
MatTek Announces Production and Shipping of EpiOral Tissues from European Facility to Better Service the Wider Market
MatTek Life Sciences will produce and distribute EpiOral from its production facility in Slovakia, continuing the BICO groups’ focus on providing on-demand tissues to the European market. MatTek Life Sciences, a Boston-area tissue engineering company and a part of the BICO Group, announced today its European facility in Bratislava, Slovakia, will begin producing and shipping EpiOral, a ...
-
CELLINK and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence
CELLINK, a leading global provider of bioprinting technologies, and the University of California, San Diego (UCSD), a world-renowned research institution, are pleased to announce their partnership to establish a 3D bioprinting Centre of Excellence. This partnership aims to facilitate the utilization of advanced bioprinting technologies and promote cutting-edge research in the fields of drug ...
By CELLINK
-
CELLINK and Atelerix team up to enable the shipping at room temperature of fragile 3D bioprinted constructs by the world’s bioprinting community
CELLINK and Atelerix announced today a partnership to bring to market Atelerix’s portfolio of innovative hydrogel biological encapsulation products, which preserve fragile biological samples for shipping at room temperature. Conventional shipping methods often involve storing cells and tissues in liquid nitrogen or dry ice, which requires a freeze-thaw process notorious for ...
By Atelerix Ltd
-
Poietis and Prometheus, division of skeletal tissue engineering of KU Leuven, enter into a Collaborative Research Agreement focused on 3D Bioprinting for skeletal ATMPs.
Poietis, leading bioprinting company and Prometheus, Division of Skeletal Tissue Engineering at KU Leuven, entered into a 2-years Collaborative Research Agreement focused on high-precision 3D Bioprinting of tissue engineered Advanced Therapeutic Medicinal Products (ATMPs) for skeletal regeneration. Prometheus focuses on the bench-to-bedside clinical translation of increasingly ...
By Poietis
-
Poietis signs a clinical research collaboration contract with the Assistance Publique – Hôpitaux de Marseille (AP-HM) to prepare the first clinical trial of a bioprinted skin.
Poietis, leading bioprinting company, and the « Assistance Publique – Hôpitaux de Marseille » (AP-HM) announced today that they have entered into a partnership through the signature the 20th of January of a clinical research collaboration contract on a bioprinted tissue engineering product. The objective of this agreement is to carry out within two years a Phase I clinical ...
By Poietis
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you